腔内导管射频消融术治疗食管恶性梗阻的临床价值

Clinical value of the transluminal radiofrequency catheter ablation for malignant esophageal obstruction

  • 摘要: 目的:探讨腔内导管RFA(RFCA)治疗食管恶性梗阻的临床价值。
    方法:采用回顾性横断面描述性研究方法。收集2013年3月至2016年3月山东省医学科学院附属医院收治的52例行RFCA食管恶性梗阻患者的临床病理资料。采用双通道内镜及X线下双极RFA治疗。观察指标:(1)术中及术后情况:手术情况、手术时间、消融时间、术后并发症、术后住院时间。(2)随访情况。 采用门诊和电话方式进行随访,了解患者后续治疗、生存及食管梗阻复发情况。随访时间截至2016年6月。正态分布的计量资料采用平均数(范围)表示。
    结果:(1)术中及术后情况:52例患者均成功完成RFCA治疗,术中无误吸、窒息、出血、穿孔等并发症发生,治疗后梗阻消除,X线透视示食管通畅。52例患者平均手术时间为58 min(20~71 min),平均消融时间为23 min(8~42 min);术后第2天开始进流质食物,第3天恢复正常饮食,无梗阻感。52例患者中,1例术后发生低血压,予补液扩容后恢复正常;5例术后胸骨后疼痛,对症治疗2 d缓解;其余46例患者术后无并发症发生。52例患者平均术后住院时间为3 d(1~5 d)。(2)随访情况: 52例患者均获得术后随访,随访时间为3~24个月,中位随访时间为13个月。术后17例患者行单纯血管介入治疗,15例行血管介入治疗联合全身化疗,14例行单纯全身化疗,其余6例患者未行任何抗肿瘤治疗。随访期间,9例患者无食管梗阻发生;26例再次出现食管梗阻,发生时间分别为术后3~8个月,其中 20例再次行双通道内镜及X线下双极RFCA治疗后缓解,6例因极度衰竭仅行静脉营养支持治疗;17例患者因肿瘤晚期恶病质死亡。
    结论:RFCA治疗食管恶性梗阻安全有效,近期疗效较好。

     

    Abstract: Objective:To investigate the clinical value of the transluminal radiofrequency catheter ablation (RFCA) for malignant esophageal obstruction.
    Methods:The retrospective crosssectional descriptive study was conducted. The clinicopathological data of 52 patients with malignant esophageal obstruction who underwent transluminal RFCA at the Affiliated Hospital of Shandong Academy of Medical Science between March 2013 and March 2016 were collected. Patients received the bipolar radiofrequency ablation (RFA) under dualchannel endoscopy and Xray. Observation indicators: (1) intra and postoperative situations: operation situations, operation time, time of RFA, postoperative complications and duration of postoperative hospital stay, (2) followup. Followup using outpatient examination and telephone interview was performed to detect the subsequent treatment, survival of patients and recurrence of esophageal obstruction up to June 2016. Measurement data with normal distribution were represented as average (range).
    Results:(1) Intra and postoperative situations: 52 patients underwent successful RFCA, without the occurrence of aspiration, asphyxia, hemorrhage and perforation. Esophageal obstruction was disappeared after treatment, Xray findings showed a smooth esophagus. Average operation time and time of RFCA were respectively 58 minutes (range, 20-71 minutes) and 23 minutes (range, 8-42 minutes). Patients took liquid food at postoperative day 2 and normal food at postoperative day 3, without the sensations of esophageal obstruction. Of 52 patients, 1 with postoperative hypotension returned to normal level through rehydration and increasing blood volume. Five patients with postoperative substernal pain were improved after 2day symptomatic treatment. And other 46 patients didn′t have postoperative complications. Average duration of postoperative hospital stay was 3 days (range, 1-5 days). (2) Followup: 52 patients were followed up for 3-24 months, with a median time of 13 months. Of 52 patients, 17 underwent single intravascular interventional therapy, 15 underwent intravascular interventional therapy combined with single systemic chemotherapy, 14 underwent single systemic chemotherapy and other 6 didn′t undergo antineoplastic therapy. During the followup, 9 patients didn′t have esophageal obstruction and 26 were complicated with esophageal obstruction again. Esophageal obstruction of 26 patients was respectively occurred at 3-8 months postoperatively, 20 patients were improved after bipolar transluminal RFCA under dualchannel endoscopy and Xray and 6 received parenteral nutrition support therapy due to extreme exhaustion. Seventeen patients died of cachexia caused by terminal malignant tumors.
    Conclusion:Transluminal RFCA is safe and effective for malignant esophageal obstruction, with a good shortterm outcome.

     

/

返回文章
返回